Showing results (241-250 of 258) with videos related to
Sort By:
Pageof 26
Dermatology and Therapy|February 12, 2026
Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 StudiesAndrew Blauvelt, Leon Kircik, Eric L Simpson, et al.The Journal of Allergy and Clinical Immunology|February 5, 2013
Atopic dermatitis: a practice parameter update 2012Lynda Schneider, Stephen Tilles, Peter Lio, et al.Pediatric Dermatology|January 17, 2020
Skin cleansing and topical product use in patients with epidermolysis bullosa: Results from a multicenter databaseLeila H Shayegan, Laura E Levin, Eloise R Galligan, et al.JAMA|September 20, 2022
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical TrialsMark G Lebwohl, Leon H Kircik, Angela Y Moore, et al.Journal of the American Academy of Dermatology|November 4, 2004
Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acneJohn J DiGiovanna, Craig B Langman, Eduardo H Tschen, et al.JAMA Dermatology|December 27, 2018
Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North AmericaJames A Feinstein, Purevsuren Jambal, Kathleen Peoples, et al.The Journal of Allergy and Clinical Immunology. in Practice|August 21, 2022
Dietary Elimination for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-AnalysisPaul Oykhman, Jared Dookie, Husam Al-Rammahy, et al.Pediatric Dermatology|June 14, 2023
Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelinesElaine C Siegfried, Lisa M Arkin, Yvonne E Chiu, et al.The Journal of Allergy and Clinical Immunology. in Practice|January 16, 2021
Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate to Severe Atopic DermatitisMark Boguniewicz, Lisa A Beck, Lawrence Sher, et al.JAMA Dermatology|October 23, 2024
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis: Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 WeeksAmy S Paller, Pedro Mendes-Bastos, Elaine Siegfried, et al.Pageof 26